TipRanks
Advertisement
Advertisement

LQDA Stock Latest News

Liquidia’s LIQ861 Transition Study Adds Fresh Momentum to the PAH Investment Story
Company AnnouncementsLiquidia’s LIQ861 Transition Study Adds Fresh Momentum to the PAH Investment Story
4h ago
LQDA
Liquidia price target lowered to $58 from $130 at H.C. Wainwright
PremiumThe Fly
Liquidia price target lowered to $58 from $130 at H.C. Wainwright
10h ago
LQDA
Liquidia downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Liquidia downgraded to Equal Weight from Overweight at Wells Fargo
19h ago
LQDA
UTHR
Liquidia falls -14.6%
PremiumThe Fly
Liquidia falls -14.6%
1d ago
LQDA
Liquidia falls -15.7%
PremiumThe Fly
Liquidia falls -15.7%
1d ago
LQDA
Exxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
PremiumThe FlyExxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
1d ago
BP
ED
Unusually active option classes on open October 1st
Premium
The Fly
Unusually active option classes on open October 1st
1d ago
ACN
IBM
Morning Movers: Alphabet up after unveiling latest Gemini model
Premium
The Fly
Morning Movers: Alphabet up after unveiling latest Gemini model
1d ago
MU
NU
Liquidia downgraded to Outperform from Strong Buy at Raymond James
PremiumThe Fly
Liquidia downgraded to Outperform from Strong Buy at Raymond James
1d ago
LQDA
UTHR
United Therapeutics’ path to $1,000 ‘just got easier,’ says Cantor Fitzgerald
PremiumThe Fly
United Therapeutics’ path to $1,000 ‘just got easier,’ says Cantor Fitzgerald
1d ago
LQDA
UTHR
Liquidia price target lowered to $40 from $92 at BofA
PremiumThe Fly
Liquidia price target lowered to $40 from $92 at BofA
1d ago
LQDA
UTHR
Liquidia downgraded to Neutral from Buy at BTIG
PremiumThe Fly
Liquidia downgraded to Neutral from Buy at BTIG
1d ago
LQDA
UTHR
United Therapeutics upgraded to Buy from Neutral at BTIG
PremiumThe FlyUnited Therapeutics upgraded to Buy from Neutral at BTIG
1d ago
LQDA
UTHR
Liquidia Faces Adverse Patent Ruling on YUTREPIA
Premium
Company Announcements
Liquidia Faces Adverse Patent Ruling on YUTREPIA
2d ago
8K
LQDA
Analyst Maintains Buy on Liquidia but Cuts Price Target to $70 After Adverse Patent Ruling
Premium
Ratings
Analyst Maintains Buy on Liquidia but Cuts Price Target to $70 After Adverse Patent Ruling
2d ago
LQDA
Patent ruling ‘a meaningful positive’ for United Therapeutics, says RBC Capital
PremiumThe Fly
Patent ruling ‘a meaningful positive’ for United Therapeutics, says RBC Capital
2d ago
LQDA
UTHR
Liquidia shares plummet after court ruling on patent infringement claims
PremiumThe Fly
Liquidia shares plummet after court ruling on patent infringement claims
2d ago
LQDA
UTHR
Liquidia to resume trading at 1:40 pm ET
PremiumThe Fly
Liquidia to resume trading at 1:40 pm ET
2d ago
LQDA
Liquidia says court ruled two of six ‘327 patent claims infringed by company
PremiumThe Fly
Liquidia says court ruled two of six ‘327 patent claims infringed by company
2d ago
LQDA
MNKD
Judge upholds claims 1, 14 of United Therapeutics’ ‘327 patent
PremiumThe FlyJudge upholds claims 1, 14 of United Therapeutics’ ‘327 patent
2d ago
LQDA
UTHR
United Therapeutics up 13% to $543.85 following Liquidia patent ruling
Premium
The Fly
United Therapeutics up 13% to $543.85 following Liquidia patent ruling
2d ago
LQDA
UTHR
Liquidia falls -24.7%
Premium
The Fly
Liquidia falls -24.7%
2d ago
LQDA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >